Arrowhead Pharmaceuticals (ARWR) Tax Provisions (2021 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Tax Provisions of $7000.0 for Q1 2026, down 75.86% on a QoQ basis from $29000.0 in Q4 2025, and down 99.6% year-over-year from $1.8 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Tax Provisions (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- Quarterly Tax Provisions fell 99.6% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 721.93% YoY) and the FY2025 annual result came in at $21.4 million, up 874.09% from the prior year.
- Tax Provisions was $7000.0 for Q1 2026 at Arrowhead Pharmaceuticals, down from $29000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $20.0 million in Q3 2025 and bottomed at -$3.3 million in Q4 2023.
- A 5-year average of $2.3 million and a median of $533000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 189150.0% — and 2026, when it tumbled 99.6%.
- Arrowhead Pharmaceuticals' Tax Provisions stood at $3.8 million in 2022, then plunged by 187.53% to -$3.3 million in 2023, then jumped by 103.11% to $103000.0 in 2024, then tumbled by 71.84% to $29000.0 in 2025, then slumped by 75.86% to $7000.0 in 2026.
- Business Quant data shows ARWR's Tax Provisions at $7000.0 in Q1 2026, $29000.0 in Q4 2025, and $20.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 12.14 Bn | 10.36 Bn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | -400,000.00 |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 533,000.00 |
| Dec 31, 2023 | -3.31 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 742,000.00 |
| Sep 30, 2022 | 3.79 Mn |
| Sep 30, 2021 | 2,000.00 |